July 14-20, 2016
Last Updated: Jul 15, 2016
- Air bronchogram: A potential indicator of epidermal growth factor receptor mutation in pulmonary subsolid nodules.
Dai Jie, et al. Lung cancer (Amsterdam, Netherlands) 2016 8 22-8 - Genome-wide association study confirms lung cancer susceptibility loci on chromosomes 5p15 and 15q25 in an African-American population.
Zanetti Krista A, et al. Lung cancer (Amsterdam, Netherlands) 2016 8 33-42 - Tumor marker analyses from the phase III, placebo-controlled, FASTACT-2 study of intercalated erlotinib with gemcitabine/platinum in the first-line treatment of advanced non-small-cell lung cancer.
Mok Tony, et al. Lung cancer (Amsterdam, Netherlands) 2016 8 1-8 - EGFR Testing in Advanced Non-Small-Cell Lung Cancer, A Mini-Review.
Sheikine Yuri et al. Clinical lung cancer 2016 Jun - Predictive factors for a long-term response duration in non-squamous cell lung cancer patients treated with pemetrexed.
Park Sojung, et al. BMC cancer 2016 0 417 - Epidermal growth factor receptor-tyrosine kinase inhibitor therapy is especially beneficial to patients with exon 19 deletion compared with exon 21 L858R mutation in non-small-cell lung cancer: Systematic review and meta analysis.
Liu Yinghui, et al. Thoracic cancer 2016 7 (4) 406-14 - Evaluation of a novel saliva-based epidermal growth factor receptor mutation detection for lung cancer: A pilot study.
Pu Dan, et al. Thoracic cancer 2016 7 (4) 428-36 - Gefitinib for asymptomatic brain metastasis from advanced non-small cell lung cancer: Report of a favourable outcome.
Liu Wen-Yang, et al. Thoracic cancer 2016 7 (4) 498-502 - Pilot study of radiofrequency hyperthermia in combination with gefitinib in gefitinib-effective patients with advanced NSCLC.
Qin Yijia, et al. Thoracic cancer 2016 7 (4) 422-7 - Prospective study of the UGT1A1*27 gene polymorphism during irinotecan therapy in patients with lung cancer: Results of Lung Oncology Group in Kyusyu (LOGIK1004B).
Fukuda Minoru, et al. Thoracic cancer 2016 7 (4) 467-72 - Nontuberculous Mycobacteria Infection and Prognosis after Surgery of Lung Cancer: A Retrospective Study.
Yamanashi Keiji, et al. The Thoracic and cardiovascular surgeon 2016 7 - Genetic variants in regulatory regions of microRNAs are associated with lung cancer risk.
Xie Kaipeng, et al. Oncotarget 2016 6 - USP7 inhibitors, downregulating CCDC6, sensitize lung neuroendocrine cancer cells to PARP-inhibitor drugs.
Malapelle Umberto, et al. Lung cancer (Amsterdam, Netherlands) 2016 6 - Comparison of plasma and tissue samples in epidermal growth factor receptor mutation by ARMS in advanced non-small cell lung cancer.
Ma MeiLi, et al. Gene 2016 6 - Impact of active smoking on survival of patients with metastatic lung adenocarcinoma harboring an epidermal growth factor receptor (EGFR) mutation.
Erdogan Bulent, et al. Bosnian journal of basic medical sciences / Udruzenje basicnih mediciniskih znanosti = Association of Basic Medical Sciences 2016 7
- Human (30)
- Pathogen (0)
- Human (3851)
- Pathogen (0)
- Human (60)
- Pathogen (0)
- Huamn (4)
- Pathogen (0)
No hay comentarios:
Publicar un comentario